Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1.78% is 94% above its 3-year average of -28.27%, near the high end of its 3-year range (-61.74%–-1.78%).
As of the fiscal period ended Friday, July 31, 2026. 94.82% above its 12-month average of -34.29%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-07-31): -1.78%.
RETURN ON INVESTED CAPITAL (ROIC)
-1.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-34.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-26.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+94.82%
CURRENT VS 3Y AVG
+93.29%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+95.01%
vs the sector median at left
enGene Holdings Inc.
Market Cap
$120.92M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-34.29%
3Y Avg
-26.50%
5Y Avg
N/A
Market Cap
$121.23M
Return on Invested Capital (ROIC)
-28.87%
TTM Avg
-28.06%
3Y Avg
-25.36%
5Y Avg
-20.47%
Market Cap
$121.37M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$120.39M
Return on Invested Capital (ROIC)
-142.06%
TTM Avg
-89.80%
3Y Avg
-79.42%
5Y Avg
-61.57%
Market Cap
$119.38M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$119.23M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$117.61M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$124.90M
Return on Invested Capital (ROIC)
-74.08%
TTM Avg
-72.79%
3Y Avg
-71.36%
5Y Avg
-64.12%
Market Cap
$125.14M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enGene Holdings Inc. (ENGN) | $120.92M | -1.78% | -34.29% | -26.50% | N/A |
| Seer, Inc. (SEER)vs › | $121.23M | -28.87% | -28.06% | -25.36% | -20.47% |
| Cibus, Inc. (CBUS)vs › | $121.37M | -17.99% | -23.22% | -53.77% | -63.92% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.39M | -142.06% | -89.80% | -79.42% | -61.57% |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.38M | -50.67% | -131.41% | -97.53% | -74.13% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.23M | -61.84% | -30.30% | -57.06% | -116.42% |
| BGM Group Ltd. (BGM)vs › | $117.61M | -3.19% | -2.23% | -1.75% | 1.24% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.90M | -74.08% | -72.79% | -71.36% | -64.12% |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.14M | -137.40% | -133.78% | -372.93% | -315.43% |
| Coya Therapeutics, Inc. (COYA)vs › | $115.61M | -0.05% | -44.27% | -81.25% | -78.53% |
ROIC
-1.8%
ROE
-2.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -1.78% |
| 2026-04-30 | -23.79% |
| 2026-01-31 | -40.55% |
| 2025-10-31 | -61.74% |
| 2025-07-31 | -43.59% |
| 2025-04-30 | -34.81% |
| 2025-01-31 | -28.40% |
| 2024-10-31 | -20.93% |
| 2024-07-31 | -21.66% |
| 2024-04-30 | -16.73% |
| 2024-01-31 | -37.05% |
| 2023-10-31 | -31.68% |
| 2023-07-31 | -16.97% |
| 2023-04-30 | -16.16% |
